Table 2. Child Behavior Outcomes.
Outcome | VIPP-SD groupa | UC groupa | Adjusted mean difference (95% CI)b | Standardized effect size (95% CI)c | P value | ||
---|---|---|---|---|---|---|---|
No. | Mean (SD) | No. | Mean (SD) | ||||
Primary outcome | |||||||
Preschool Parental Account of Childhood Symptoms: total | |||||||
Baseline | 151 | 33.5 (9.0) | 149 | 32.4 (10.6) | NA | NA | NA |
5-mo Follow-up | 140 | 28.8 (9.2) | 146 | 30.3 (9.9) | 2.03 (0.06 to 4.01) | 0.20 (0.01 to 0.40) | .04 |
Preschool Parental Account of Childhood Symptoms: conduct | |||||||
Baseline | 151 | 16.0 (5.8) | 149 | 15.5 (6.4) | NA | NA | NA |
5-mo Follow-up | 140 | 14.8 (5.1) | 146 | 15.8 (5.4) | 1.61 (0.44 to 2.78) | 0.30 (0.08 to 0.51) | .007 |
Preschool Parental Account of Childhood Symptoms: ADHD | |||||||
Baseline | 151 | 17.5 (5.8) | 149 | 16.9 (6.6) | NA | NA | NA |
5-mo Follow-up | 140 | 14.0 (6.1) | 146 | 14.5 (6.2) | 0.29 (−1.06 to 1.65) | 0.05 (−0.17 to 0.27) | .67 |
Secondary outcomes | |||||||
Child Behavior Checklist: total | |||||||
Baseline | 151 | 40.7 (21.7) | 149 | 42.7 (21.1) | NA | NA | NA |
5-mo Follow-up | 140 | 32.5 (20.6) | 145 | 37.2 (21.0) | 3.24 (−0.06 to 6.54) | 0.15 (0.00 to 0.31) | .05 |
Strength and Difficulties Questionnaire: total | |||||||
Baseline | 150 | 13.8 (4.8) | 149 | 14.0 (4.7) | NA | NA | NA |
5-mo Follow-up | 140 | 11.3 (5.1) | 145 | 12.2 (5.2) | 0.93 (−0.03 to 1.9) | 0.18 (−0.01 to 0.36) | .06 |
Abbreviations: ADHD, attention-deficit/hyperactivity disorder; NA, not applicable; UC, usual care; VIPP-SD, Video-feedback Intervention to promote Positive Parenting and Sensitive Discipline.
Lower scores indicate fewer behavior problems.
Difference in mean is the difference between treatment groups from linear regression analysis of the outcome measure on the baseline score of that same measurement, on treatment center, on randomized group, on length of follow-up, on age of child, and on number of caregivers participating (all treated as fixed effects). Positive differences represent greater adjusted decreases in symptoms in the VIPP-SD rather than in the UC group.
Standardized effect size is the standardized difference in mean (adjusted as above) and is presented as Cohen d, the difference in mean divided by the SD of controls at follow-up. Cohen d values of 0.4 to 0.6 represent typical values of Cohen d. These values do not directly relate to the clinical importance of the results because an assessment of a characteristic of each individual scale or subscale is required.